Cargando…

Plasma long non-coding RNA BACE1 as a novel biomarker for diagnosis of Alzheimer disease

BACKGROUNDS: Long non-coding RNA (LncRNA) have been reported to be involved in the pathogenesis of neurodegenerative diseases, but whether it can serve as a biomarker for Alzheimer disease (AD) is not yet known. METHODS: The present study selected four specific LncRNA (17A, 51A, BACE1 and BC200) as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feng, Liang, Liao, Yu-Ting, He, Jin-Cai, Xie, Cheng-Long, Chen, Si-Yan, Fan, Hui-Hui, Su, Zhi-Peng, Wang, Zhen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5761117/ https://www.ncbi.nlm.nih.gov/pubmed/29316899 http://dx.doi.org/10.1186/s12883-017-1008-x

Ejemplares similares

BACE1: from biomarker to Alzheimer’s disease therapeutical target
por: Cervellati, Carlo, et al.
Publicado: (2021)

Platelet BACE1 levels as a possible biomarker for Alzheimer’s disease
por: Decourt, Boris, et al.
Publicado: (2013)

The effect of BACE1-AS on β-amyloid generation by regulating BACE1 mRNA expression
por: Li, Fan, et al.
Publicado: (2019)

BACE1 in the retina: a sensitive biomarker for monitoring early pathological changes in Alzheimer's disease
por: Li, Lan, et al.
Publicado: (2016)

Role of BACE1 in Alzheimer’s synaptic function
por: Das, Brati, et al.
Publicado: (2017)

The Emerging Roles of the β-Secretase BACE1 and the Long Non-coding RNA BACE1-AS in Human Diseases: A Focus on Neurodegenerative Diseases and Cancer
por: Sayad, Arezou, et al.
Publicado: (2022)

Elevated plasma levels of exosomal BACE1-AS combined with the volume and thickness of the right entorhinal cortex may serve as a biomarker for the detection of Alzheimer's disease
por: Wang, Dewei, et al.
Publicado: (2020)

The Alzheimer's disease β-secretase enzyme, BACE1
por: Cole, Sarah L, et al.
Publicado: (2007)

Highlights in BACE1 Inhibitors for Alzheimer's Disease Treatment
por: Coimbra, Judite R. M., et al.
Publicado: (2018)

Post-Translational Modifications of BACE1 in Alzheimer's Disease
por: Wen, Wen, et al.
Publicado: (2022)

Long non-coding RNA BACE1-AS is an independent unfavorable prognostic factor in liver cancer
por: Nie, Yuanyuan, et al.
Publicado: (2020)

Alzheimer's disease BIN1 coding variants increase intracellular Aβ levels by interfering with BACE1 recycling
por: Perdigão, Catarina, et al.
Publicado: (2021)

BACE1, the Alzheimer's beta-secretase enzyme, in health and disease
por: Vassar, Robert
Publicado: (2012)

BACE1, the Alzheimer’s beta-secretase enzyme, in health and disease
por: Vassar, Robert
Publicado: (2013)

BACE1 inhibitor drugs in clinical trials for Alzheimer’s disease
por: Vassar, Robert
Publicado: (2014)

BACE1 inhibition as a therapeutic strategy for Alzheimer's disease
por: Vassar, Robert
Publicado: (2016)

BACE-1 and γ-Secretase as Therapeutic Targets for Alzheimer’s Disease
por: Maia, Miguel A., et al.
Publicado: (2019)

BACE2: A Promising Neuroprotective Candidate for Alzheimer’s Disease
por: Yeap, Yee Jie, et al.
Publicado: (2023)

Functional insights from targeted imaging BACE1: the first near-infrared fluorescent probe for Alzheimer’s disease diagnosis
por: Bi, Anyao, et al.
Publicado: (2022)

BACE1 Dynamics Upon Inhibition with a BACE Inhibitor and Correlation to Downstream Alzheimer’s Disease Markers in Elderly Healthy Participants
por: Timmers, Maarten, et al.
Publicado: (2017)

PS1 Affects the Pathology of Alzheimer’s Disease by Regulating BACE1 Distribution in the ER and BACE1 Maturation in the Golgi Apparatus
por: Li, Nuomin, et al.
Publicado: (2022)

Opposite Roles of δ- and μ-Opioid Receptors in BACE1 Regulation and Alzheimer’s Injury
por: Xu, Yuan, et al.
Publicado: (2020)

BACE1 gene variants do not influence BACE1 activity, levels of APP or Aβ isoforms in CSF in Alzheimer's disease
por: Sjölander, Annica, et al.
Publicado: (2010)

The BACE‐1 inhibitor CNP520 for prevention trials in Alzheimer's disease
por: Neumann, Ulf, et al.
Publicado: (2018)

BACE1 Inhibitors for Alzheimer’s Disease: The Past, Present and Any Future?
por: Bazzari, Firas H., et al.
Publicado: (2022)

BACE1 SUMOylation increases its stability and escalates the protease activity in Alzheimer’s disease
por: Bao, Jian, et al.
Publicado: (2018)

Plasma biomarkers and genetics in the diagnosis and prediction of Alzheimer’s disease
por: Stevenson-Hoare, Joshua, et al.
Publicado: (2022)

PT573. The effects of intestinal endotoxemia on APP, PS1 and BACE expression in Alzheimer’s disease
por: Han, Bai, et al.
Publicado: (2016)

Attenuated ability of BACE1 to cleave the amyloid precursor protein via silencing long noncoding RNA BACE1-AS expression
por: LIU, TE, et al.
Publicado: (2014)

The Basic Biology of BACE1: A Key Therapeutic Target for Alzheimer’s Disease
por: Cole, S.L, et al.
Publicado: (2007)

Sorting out the cell biology of Alzheimer’s disease: focus on BACE1 and APP
por: Annaert, Wim
Publicado: (2012)

Cerebrospinal Fluid BACE1 Activity and Brain Amyloid Load in Alzheimer's Disease
por: Grimmer, Timo, et al.
Publicado: (2012)

The β-secretase enzyme BACE1 as a therapeutic target for Alzheimer's disease
por: Vassar, Robert, et al.
Publicado: (2011)

In Silico Design of BACE1 Inhibitor for Alzheimer's Disease by Traditional Chinese Medicine
por: Huang, Hung-Jin, et al.
Publicado: (2014)

Stepping closer to treating Alzheimer’s disease patients with BACE1 inhibitor drugs
por: Yan, Riqiang
Publicado: (2016)

Functions of the Alzheimer’s Disease Protease BACE1 at the Synapse in the Central Nervous System
por: Munro, Kathryn M., et al.
Publicado: (2016)

BACE1 Translation: At the Crossroads Between Alzheimer’s Disease Neurodegeneration and Memory Consolidation
por: Guix, Francesc X., et al.
Publicado: (2019)

BACE1 role in Alzheimer's disease and other dementias: from the theory to the practice
por: Cervellati, Carlo, et al.
Publicado: (2021)

Repurposing food molecules as a potential BACE1 inhibitor for Alzheimer’s disease
por: Mukerjee, Nobendu, et al.
Publicado: (2022)

Allostery Inhibition of BACE1 by Psychotic and Meroterpenoid Drugs in Alzheimer’s Disease Therapy
por: Ugbaja, Samuel C., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_oadild9v9o5uonimi97esu114b